Latest News - Thermo Fisher Scientific
Top Corporates Hub
Thermo Fisher Scientific
Why Thermo Fisher Scientific (TMO) Is Back In The Spotlight
08.10.2026 14:08
Thermo Fisher Scientific (TMO) just appeared in the headlines after its clinical research business signed a Study Start-Up Agreement with Quantum BioPharma to run a Phase 2 multiple sclerosis trial for Lucid-MS. For context, Thermo Fisher Scientific’s share price is at US$662.06, with a 30-day share price return of 7.87% and a 90-day gain of 26.18%, while the 1-year total shareholder return of 23.91% points to momentum that has been building rather than fading. Capitalize on the momentum...
PCR Market Report Forecasts qPCR, Digital PCR and Multiplex Testing Growth, Profiling 89 Companies Including Roche and Thermo Fisher
08.10.2026 10:47
Five-year forecasts by application, technology, product and setting, from clinical labs to point of care, as syndromic multiplex panels reshape molecular diagnostics after the pandemic.Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- "PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place Forecasting and Analysis" has been added to ResearchAndMarkets.com's offering. The pandemic accelerated the adoption of polymerase chain reaction technology and est
Pharmaceutical CRO Market Forecasts Growth from $45.33B (2025) to $83.31B by 2033, Profiling IQVIA, ICON, Thermo Fisher, Medpace & 5 Other Key Players
08.10.2026 08:06
230-Page Report Shows How 569,000+ Registered Clinical Studies, CRO Consolidation and AI-Driven Trial Models Are Reshaping Outsourcing Strategy for Pharma and Biotech LeadersDublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- "Pharmaceutical CRO Market Size, Share & Trends Analysis Report by Type, Molecule Type, Services, Therapeutic Area, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering. The global pharmaceutical CRO market was valued at an estimated USD 45.33
Is This the Right Time to Add TMO Stock to Your Portfolio?
07.10.2026 12:45
Thermo Fisher's growth gains momentum through innovation, acquisitions and broad end-market strength, but macroeconomic and currency risks remain.
Cell-Based Assay & High Content Screening Market Report Reveals Why Technology Is Outpacing the Market, Profiling Thermo Fisher, Roche, Sartorius, Revvity & 50 Other Key Players
07.10.2026 11:46
281-Page Report Tracks Post-Pandemic Research Growth Across Pharma, Research and Industry/Cosmetic Users as 3D Assays, Automation and Immuno-oncology Reshape Drug DiscoveryDublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- "Cell-Based Assay & High Content Screening Market 2025-2029 - Forecasts by User and Product, with Executive and Consultant Guides" has been added to ResearchAndMarkets.com's offering. Research and Markets has published Cell-Based Assay & High Content Screening Market 2025-2029 - Foreca
Thermo Fisher Scientific Proteomics Technologies Enable Discovery of More Than 2,500 New Biological Associations in PRECISE-SG100K Study
05.10.2026 12:30
WALTHAM, Mass., October 05, 2026--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its strategic collaboration with Precision Health Research, Singapore (PRECISE) and Nanyang Technological University, Singapore (NTU Singapore) has led to the discovery of more than 2,500 previously unreported genetic-protein associations. By combining Thermo Fisher’s complementary proteomics technologies with PRECISE-SG100K's large-scale health and genomic data, researchers
3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
05.10.2026 12:18
GenAI offers growth opportunities for GMED, ISRG and TMO, but evolving regulations and industry risks are likely to shape adoption.
Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in Focus
05.10.2026 11:09
TMO, CRCT and SHOP delivered strong gains as Zacks highlighted standout performers across its research portfolios.
Custom Recombinant Proteins Market - Global Strategic Business Report 2026 | Capture the $10 Billion 2030 Shift as Thermo Fisher Scientific, Merck, GenScript, and Sino Biological Redefine Scale
05.10.2026 10:15
Dublin, Oct. 05, 2026 (GLOBE NEWSWIRE) -- "Custom Recombinant Proteins Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global custom recombinant proteins market was valued at US$5.3 billion in 2024 and is projected to reach US$10 billion by 2030, expanding at a compound annual growth rate (CAGR) of 11.2%. Market growth is supported by rising biopharmaceutical research and development, expanding biologics pipelines, advances in protein engineeri
JPMorgan Adds New Stocks to Its October Favorites List
05.10.2026 06:07
JPMorgan adds American Express, Liberty Energy and Thermo Fisher to its October stock picks after a mixed September.
Cell and Gene Therapy Bio-Manufacturing Market Global Report 2026: Market to Surge to $21.46 Billion by 2030 as Thermo Fisher Scientific, Merck KGaA, Lonza and Samsung Biologics Accelerate Automation
01.10.2026 15:09
Boost ROI with scalable viral-vector platforms, automated single-use processing, digital quality control, and expanded CDMO capacity through partnerships and acquisitions.Dublin, Oct. 01, 2026 (GLOBE NEWSWIRE) -- "Cell and Gene Therapy Bio-Manufacturing Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global cell and gene therapy biomanufacturing market is experiencing rapid expansion as advanced therapies move from research and clinical development toward comm
Biomarkers Market Forecasts Growth from $67.95B (2026) to $112.10B by 2031, Profiling Roche, Abbott, Thermo Fisher & Qiagen
01.10.2026 08:42
The global biomarkers market is projected to grow from USD 67.95 billion in 2026 to USD 112.10 billion by 2031, registering a 10.5% CAGR. Growth is driven by precision medicine, companion diagnostics, AI, bioinformatics, digital pathology and multi-omics technologies. Predictive biomarkers led the efficacy segment in 2025, while immunoassays held the largest technology share. Asia Pacific is forecast to be the fastest-growing region. Key players include Roche, Abbott, Thermo Fisher Scientific, Q
Radiation Detection, Monitoring & Safety Market Forecasts Growth from $3.80B (2026) to $5.68B by 2031, Profiling Fortive, Thermo Fisher & Mirion Technologies
01.10.2026 08:29
The global radiation detection, monitoring & safety market is projected to grow from USD 3.80 billion in 2026 to USD 5.68 billion by 2031, at an 8.4% CAGR. Growth is driven by expanding medical imaging and radiotherapy, nuclear energy investments, regulatory requirements, and security concerns. Detection and monitoring products and radiation detectors lead the market, while Asia Pacific is set for significant growth. Key players include Fortive, Thermo Fisher Scientific, Mirion Technologies, Fuj
Fetal Bovine Serum Market Outlook 2026-2035 - Featuring Profiles of Leading Companies Thermo Fisher Scientific, Merck KGaA, and Cytiva
30.09.2026 08:46
Fetal Bovine Serum Market Gains Momentum as Stem Cell Research, Vaccine Innovation and Advanced Therapies Drive Demand for High-Quality, Ethically Sourced ProductsDublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "Fetal Bovine Serum Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. The global fetal bovine serum market was valued at USD 1.1 billion in 2025 and is projected to reach USD 2.3 billion by 2035, expanding
Thermo Fisher (TMO) Is Turning Innovation Into Recurring Revenue. Can Margins Follow?
29.09.2026 01:24
On September 23, Thermo Fisher Scientific Inc. (NYSE:TMO) announced the launch of the Gibco CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed media designed to accelerate cell growth and protein production for CHO-K1 host lines used in biologics and biosimilars development. Offered in liquid and dry powder formats, the ready-to-use catalog panel enables […]
Will Thermo Fisher’s New cGMP CHO-K1 Panel and MRD Moves Change Thermo Fisher Scientific's (TMO) Narrative
29.09.2026 01:09
Earlier this month, Thermo Fisher Scientific announced several product and collaboration updates, including the cGMP-ready Gibco CHO-K1 Catalog Panel for bioprocessing, a reseller agreement to distribute Evosep’s Eno separation platform in proteomics workflows, and expanded involvement in molecular residual disease programs with Biodesix and Memorial Sloan Kettering. Together, these moves deepen Thermo Fisher’s role across biologics manufacturing, advanced proteomics, and ctDNA-based cancer...
Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests
28.09.2026 14:03
BDSX advances two blood-based MRD programs with Bio-Rad and Thermo Fisher to broaden access to cancer monitoring.
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
28.09.2026 12:00
WALTHAM, Mass., September 28, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2026 before the market opens on Wednesday, October 21, 2026, and will hold a conference call on the same day at 7:00 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations.
Magnetic Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership
28.09.2026 08:07
Demand is rising in diagnostics, precision medicine and biopharma research, while nanotechnology, automation and AI unlock targeted therapies and high-throughput workflows.Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Magnetic Beads - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global magnetic beads market was valued at an estimated US$3.3 billion in 2025 and is projected to reach US$7.4 billion by 2032, advancing at a compound annual growth rate (CAG
Global Grignard Reagents Market Outlook and Forecast, 2026–2032 - Market to Reach USD 7.87 Billion as Safer, AI-Enabled Production Expands Opportunities for Merck KGaA, Thermo Fisher Scientific, and Tokyo Chemical Industry
28.09.2026 08:02
Boost ROI via automated closed handling, resilient sourcing, tailored portfolios, quality-by-design, validated AI, compliance mapping and lifecycle stewardship.Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Grignard Reagents Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Grignard Reagents Market research report provides a comprehensive assessment of industry growth, production trends, applications, technologies, and geographic opportunities. The market